Study of antimutagenic activity of medicinal plant infusions Crataegus sanguinea Pall. family Rosaceae in plant test systems

BIO Web of Conferences, 2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1051/bioconf/202410003011
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Medicinal plants, integral to traditional medicine systems, are rich sources of biologically active substances that benefit physiological and biochemical processes within living organisms. Amongst these activities, antimutagenic and genoprotective properties stand out, offering mitigation against genotoxic effects induced by adverse environmental factors on genetic material. This study delves into the mutagenic and antimutagenic capacities of aqueous and alcoholic infusions derived from Crataegus sanguinea Pall. (Rosaceae family), utilising Hordeum vulgare L. as a plant-based test subject. The assessment employed the metaphase chromosome analysis technique. Results indicate that these infusions exhibit no mutagenic activity, with the level of chromosomal aberrations in barley seeds treated with these infusions not exceeding the natural mutation rate in a statistically significant manner. When infusions were combined with Methyl methanesulfonate (positive control) exposure – irrespective of exposure sequence – a statistically significant attenuation in MMS-induced mutagenesis was observed (p<0.01). A 56-60% reduction quantified the antimutagenic efficacy of C.sanguinea infusions. This metric underscores the infusions’ capability to inhibit MMS-induced mutagenesis by 50–60%, positioning these water and alcohol-based extracts of common hawthorn as viable candidates for safeguarding against chemically induced mutagenic factors.